Analysen von Richard Vosser
| 05.12.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.12.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | Sanofi Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 30.11.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.11.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 09.11.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.11.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 31.10.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 30.10.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 27.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 24.10.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 23.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.10.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 23.10.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 20.10.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 19.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.10.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.10.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 09.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.09.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 28.09.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 21.09.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 20.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.09.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.09.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.08.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.08.23 | Roche Underweight | JP Morgan Chase & Co. | |